- Home
- HCI vs IRON Comparison
HCI vs IRON Comparison
Compare HCI & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- IRON
- Stock Information
- Founded
- HCI 2006
- IRON 2017
- Country
- HCI United States
- IRON United States
- Employees
- HCI N/A
- IRON N/A
- Industry
- HCI Property-Casualty Insurers
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- HCI Finance
- IRON Health Care
- Exchange
- HCI Nasdaq
- IRON Nasdaq
- Market Cap
- HCI 1.7B
- IRON 1.8B
- IPO Year
- HCI N/A
- IRON N/A
- Fundamental
- Price
- HCI $146.76
- IRON $54.75
- Analyst Decision
- HCI Strong Buy
- IRON Strong Buy
- Analyst Count
- HCI 4
- IRON 11
- Target Price
- HCI $181.25
- IRON $92.64
- AVG Volume (30 Days)
- HCI 173.4K
- IRON 423.3K
- Earning Date
- HCI 08-07-2025
- IRON 08-07-2025
- Dividend Yield
- HCI 1.09%
- IRON N/A
- EPS Growth
- HCI 4.05
- IRON N/A
- EPS
- HCI 10.46
- IRON N/A
- Revenue
- HCI $759,870,000.00
- IRON N/A
- Revenue This Year
- HCI $19.25
- IRON N/A
- Revenue Next Year
- HCI $4.08
- IRON N/A
- P/E Ratio
- HCI $14.03
- IRON N/A
- Revenue Growth
- HCI 20.95
- IRON N/A
- 52 Week Low
- HCI $83.65
- IRON $30.82
- 52 Week High
- HCI $176.40
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- HCI 38.74
- IRON 59.95
- Support Level
- HCI $139.93
- IRON $51.01
- Resistance Level
- HCI $153.86
- IRON $55.52
- Average True Range (ATR)
- HCI 4.82
- IRON 2.43
- MACD
- HCI -0.77
- IRON -0.02
- Stochastic Oscillator
- HCI 32.66
- IRON 88.42
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.